# Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dulaglutide-versus-insulin-glargine-in-patients-with-type-2-diabetes-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Katherine R Tuttle,Mark Lakshmanan,Brian Rayner,Robert S. Busch,Alan G. Zimmermann,D. Bradley Woodward,Fady T. Botros |
| Citations | 645 |
| DOI | 10.1016/s2213-8587(18)30104-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2808008353 |
| PMID | 29910024 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Alan G. Zimmermann](https://scholariq.org/researchers/alan-g-zimmermann/)
- [Brian Rayner](https://scholariq.org/researchers/brian-rayner/)
- [Mark Lakshmanan](https://scholariq.org/researchers/mark-lakshmanan/)
- [Robert S. Busch](https://scholariq.org/researchers/robert-s-busch/)
- [Fady T. Botros](https://scholariq.org/researchers/fady-t-botros/)

## Paper funders

- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)

## Paper journal

- [The Lancet Diabetes & Endocrinology](https://scholariq.org/journals/the-lancet-diabetes-and-endocrinology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.